Latest Blog Posts

Diabetes Drug Latest to Contain High Levels of Potential Carcinogen

by Staff Blogger | March 3rd, 2020

A type 2 diabetes drug called metformin is the latest medication that was discovered to contain high levels of NDMA, a contaminant that’s a potential carcinogen. The substance was also found in multiple types of valsartan, a blood pressure medication, and both name brand and generic versions of Zantac, also known as ranitidine. A test

Read More

Did You Know That Many Major Drugs Have Been Recalled Over the Years?

by Staff Blogger | February 26th, 2020

During the past couple of years, two major drug recalls have been announced. First, there was Losartan blood pressure medications that contained small amounts of a cancer-causing impurity. The recall began in early January 2019 and was expanded to include several more lots of blood pressure medications. Then, a mass recall began of Zantac (ranitidine)

Read More

FDA Requests Recall of Weight Loss Drug Due to Cancer Risks

by Staff Blogger | February 19th, 2020

On Feb. 13, 2020, the U.S. Food and Drug Administration (FDA) requested that Eisai Inc., the manufacturer of weight loss medications Belviq and Belviq XR (lorcaserin), pull the products from the market. The recall is in response to data from a safety clinical trial indicating that patients who take the medications may be at an

Read More

Some Defective Drug and Product Injuries Take Years to Show Up

by Staff Blogger | February 11th, 2020

When many people think of drug injuries, they picture severe and acute reactions to medications that result in immediate symptoms like pain, swelling, rashes, and organ failure. But many drug injuries are slower acting and more insidious. Due to their defective manufacturing processes or toxic ingredients, these dangerous drugs may slowly poison the bodies of

Read More